adenosine A2A receptor antagonists (INSERM/Instituto De Medicina Molecular/University of Bonn/KU Leuven R&D/Universite Libre de Bruxelles)
N/A
Report date: 2025/06/11 20:01:15
NME
Base Information
Drug Nameadenosine A2A receptor antagonists (INSERM/Instituto De Medicina Molecular/University of Bonn/KU Leuven R&D/Universite Libre de Bruxelles)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wurzburg
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of WurzburgUniversite Libre De BruxellesInserm +[6]
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A